TRPV1 and epilepsy: Furthermore, the neuronal damage caused by complement 3 (C3) in astrocytic cultures treated with 4-AP was significantly reduced in the absence of the vanilloid receptor TRPV1, suggesting that TRPV1 in astrocytes participates in the neuronal loss elicited in epilepsy models [117].